Idiopathic Pulmonary Fibrosis

被引：1311

作者：

Lederer, David J. ^{[1
,2
]}

Martinez, Fernando J. ^{[3
]}

机构：

[1] Columbia Univ, Dept Med, Irving Med Ctr, New York, NY USA

[2] Columbia Univ, Dept Epidemiol, Irving Med Ctr, New York, NY USA

[3] Weill Cornell Med Ctr, Dept Med, New York, NY 10021 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2018年 / 378卷 / 19期

关键词：

INTERSTITIAL LUNG-DISEASE; MUC5B PROMOTER POLYMORPHISM; GASTROESOPHAGEAL-REFLUX; CLINICAL-PRACTICE; N-ACETYLCYSTEINE; DIAGNOSTIC YIELD; PIRFENIDONE; NINTEDANIB; PREVALENCE; CRYOBIOPSY;

D O I：

10.1056/NEJMra1705751

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

[No abstract available]

引用

页码：1811 / 1823

页数：13

共 100 条

[1]

P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study [J].

Abdulqawi, Rayid ;

Dockry, Rachel ;

Holt, Kimberley ;

Layton, Gary ;

McCarthy, Bruce G. ;

Ford, Anthony P. ;

Smith, Jaclyn A. .

LANCET, 2015, 385 (9974) :1198-1205

[2]

Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function [J].

Albera, Carlo ;

Costabel, Ulrich ;

Fagan, Elizabeth A. ;

Glassberg, Marilyn K. ;

Gorina, Eduard ;

Lancaster, Lisa ;

Lederer, David J. ;

Nathan, Steven D. ;

Spirig, Dominique ;

Swigris, Jeff J. .

EUROPEAN RESPIRATORY JOURNAL, 2016, 48 (03) :843-851

[3]

Short telomeres are a risk factor for idiopathic pulmonary fibrosis [J].

Alder, Jonathan K. ;

Chen, Julian J. -L. ;

Lancaster, Lisa ;

Danoff, Sonye ;

Su, Shu-Chih ;

Cogan, Joy D. ;

Vulto, Irma ;

Xie, Mingyi ;

Qi, Xiaodong ;

Tuder, Rubin M. ;

Phillips, John A., III ;

Lansdorp, Peter M. ;

Loyd, James E. ;

Armanios, Mary Y. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (35) :13051-13056

[4]

Allen RJ, 2017, LANCET RESP MED, V5, P869, DOI [10.1016/s2213-2600(17)30387-9, 10.1016/S2213-2600(17)30387-9]

[5]

[Anonymous], 2014, NEW ENGL J MED, V370, P2093

[6]

Telomerase mutations in families with idiopathic pulmonary fibrosis [J].

Armanios, Mary Y. ;

Chen, Julian J. -L. ;

Cogan, Joy D. ;

Alder, Jonathan K. ;

Ingersoll, Roxann G. ;

Markin, Cheryl ;

Lawson, William E. ;

Xie, Mingyi ;

Vulto, Irma ;

Phillips, John A., III ;

Lansdorp, Peter M. ;

Greider, Carol W. ;

Loyd, James E. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (13) :1317-1326

[7]

Occupational and environmental risk factors for idiopathic pulmonary fibrosis: A multicenter case-control study [J].

Baumgartner, KB ;

Samet, JM ;

Coultas, DB ;

Stidley, CA ;

Hunt, WC ;

Colby, TV ;

Waldron, JA .

AMERICAN JOURNAL OF EPIDEMIOLOGY, 2000, 152 (04) :307-315

[8]

A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial [J].

Birring, Surinder S. ;

Wijsenbeek, Marlies S. ;

Agrawal, Sanjay ;

van den Berg, Jan W. K. ;

Stone, Helen ;

Maher, Toby M. ;

Tutuncu, Ahmet ;

Morice, Alyn H. .

LANCET RESPIRATORY MEDICINE, 2017, 5 (10) :806-815

[9]

The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia [J].

Brownell, Robert ;

Moua, Teng ;

Henry, Travis S. ;

Elicker, Brett M. ;

White, Darin ;

Vittinghoff, Eric ;

Jones, Kirk D. ;

Urisman, Anatoly ;

Aravena, Carlos ;

Johannson, Kerri A. ;

Golden, Jeffrey A. ;

King, Talmadge E., Jr. ;

Wolters, Paul J. ;

Collard, Harold R. ;

Ley, Brett .

THORAX, 2017, 72 (05) :424-429

[10]

Drug Treatment of Idiopathic Pulmonary Fibrosis Systematic Review and Network Meta-Analysis [J].

Canestaro, William J. ;

Forrester, Sara H. ;

Raghu, Ganesh ;

Ho, Lawrence ;

Devine, Beth E. .

CHEST, 2016, 149 (03) :756-766

← 1 2 3 4 5 6 7 8 9 10 →